Vimarsana
Biggest News Aggregation in the World

Page 9 - Immunic Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunic Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunic Inc Today - Breaking & Trending Today

Immunic shares soar 48% after-hours buoyed by interim MS data - Vimarsana News

Immunic shares soar 48% after-hours buoyed by interim MS data

Shares in Immunic Inc (NASDAQ:IMUX) soared 48% in after-hours trading following the release of encouraging interim data from its phase II CALLIPER trial...

Related Topics:
Daniel VittImmunic Inc
Multiple Sclerosis Impacts 1M People In US - Immunic Reveals 'Positive' Data From Nerve Disorder Candidate - Immunic (NASDAQ:IMUX) - Vimarsana News

Multiple Sclerosis Impacts 1M People In US - Immunic Reveals 'Positive' Data From Nerve Disorder Candidate - Immunic (NASDAQ:IMUX)

Immunic Inc (NASDAQ: IMUX) announced interim data from its phase 2 CALLIPER trial of nuclear receptor-related 1 (Nurr1) activator, vidofludimus calcium (IMU-838), in patients with 

Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Atreca (NASDAQ:BCEL), Applied UV (NASDAQ:AUVI) - Vimarsana News

Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Atreca (NASDAQ:BCEL), Applied UV (NASDAQ:AUVI)

Gainers SuperCom Ltd. (NASDAQ: SPCB) shares rose 78.4% to $0.6425 in pre-market trading, after falling 13% on Monday.

Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis - Vimarsana News

Immunic Reports Positive Interim Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis

– 24-Week Data from First Half of Patients Shows Improvements in Biomarker NfL, Consistent Throughout the Overall Progressive Multiple Sclerosis P...

Immunic to Participate in Scientific Conferences in October - Vimarsana News

Immunic to Participate in Scientific Conferences in October

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...